Trial: 201712023

Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer

Phase

III

Principal Investigator

Michalski, Jeff

Disease Site

Prostate

Learn more about this study at: clinicaltrials.gov